Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
Breast Cancer
Interventions
DEVICE

Echocardiography

Two-dimensional, color Doppler, spectral Doppler, tissue Doppler and three-dimensional echocardiographic image recordings will be taken using a Philips Epiq 7C echocardiography device and X5-1 probe. Conventional parameters, additional parameters, and strain analyzes will be performed by TomTec AutoStrain Suite Software

Trial Locations (5)

Unknown

RECRUITING

Fujian Cancer Hospital, Fuzhou

RECRUITING

Dalian Friendship Hospital, Dalian

RECRUITING

Dalian Municipal Central Hospital, Dalian

RECRUITING

Liaoning Cancer Hospital & Institute, Shenyang

RECRUITING

The Third People's Hospital Of Chengdu, Chengdu

All Listed Sponsors
lead

First Hospital of China Medical University

OTHER